elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28269998-2914C28A-7DB5-430A-AE14-76BDADCC49B0
Q28269998-2914C28A-7DB5-430A-AE14-76BDADCC49B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28269998-2914C28A-7DB5-430A-AE14-76BDADCC49B0
A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study
P1433
Q28269998-2914C28A-7DB5-430A-AE14-76BDADCC49B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28269998-2914C28A-7DB5-430A-AE14-76BDADCC49B0
rank
NormalRank
type
BestRank
Statement
P1433
Pharmacology